Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554564 · ClinicalTrials.gov registry record · NA
Project VOICE: Vascular Outcomes Improvement Through Collection of PatiEnt Reported Data
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03554564: Completed NA study, sponsored by University of Michigan.
NCT03554564 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03554564, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of a digital health platform coupled with walking activity tracking for patients with Peripheral Artery Disease (PAD) and symptoms limited to claudication.
Primary Outcome
Self-reported walking adherence based on a daily log will be compared with exercise assessed using tracked walking activity during the VOICE/Fitbit phase. Adherence will be evaluated based on number of days during the study period where walking exercise was performed, and will be evaluated as a categorical (yes/no) variable.
Interventions
- BEHAVIORAL VOICE/Fitbit
- OTHER Daily self-reported exercise adherence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-08-02 |
| Est. Completion | 2019-11-13 |
| Phase | NA |
What the finished NCT03554564 record still lists
NCT03554564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which VOICE/Fitbit is the first listed.
NCT03554564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03554564 about?
NCT03554564 is a clinical study titled "Project VOICE: Vascular Outcomes Improvement Through Collection of PatiEnt Reported Data". The purpose of this study is to evaluate the feasibility of a digital health platform coupled with walking activity tracking for patients with Peripheral Artery Disease (PAD) and symptoms limited to claudication.
What is the current status of trial NCT03554564?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-08-02. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT03554564?
The interventions under investigation include: VOICE/Fitbit (BEHAVIORAL), Daily self-reported exercise adherence (OTHER).
Who is sponsoring clinical trial NCT03554564?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03554564's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI